Understanding how specific protein complexes regulate gene expression in cells

Elucidating pBAF-complex functions by chemical genetics and epigenome editing

NIH-funded research Oklahoma Medical Research Foundation · NIH-11019322

This study is looking at a special protein complex that helps control how our genes work, and it's hoping to find out how problems with this complex might lead to diseases like cancer and developmental disorders, which could help patients in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOklahoma Medical Research Foundation NIH-funded
Lab location1 site (Oklahoma City, United States)
Project IDNIH-11019322 on NIH RePORTER

What this research studies

This research investigates the functions of a specific protein complex known as the pBAF complex, which plays a crucial role in regulating gene expression and cellular processes. By using advanced techniques such as chemical genetics and epigenome editing, the researchers aim to uncover how this complex influences gene activity and chromatin structure. Patients may benefit from insights gained about how disruptions in these processes can lead to diseases like cancer and developmental disorders. The study will involve both loss-of-function and gain-of-function experiments to analyze the effects of these complexes on cellular behavior.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with cancers or genetic disorders linked to chromatin regulation.

Not a fit: Patients with conditions unrelated to chromatin dysregulation or those not diagnosed with cancer or genetic disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating diseases caused by chromatin dysregulation, including various cancers.

How similar studies have performed: Previous research has shown promising results in understanding chromatin regulation and its implications for disease, indicating that this approach has potential for success.

Where this research is happening

Oklahoma City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions cancer genomicscancer sub-typescancer subtypescancer type
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.